Compounded tirzepatide: how it works and how to get it

What compounded tirzepatide is

Tirzepatide is a dual GIP and GLP-1 receptor agonist that reduces appetite and affects blood sugar. A compounded version is prepared by a licensed pharmacy under a prescription for one patient.

Brand products exist, such as Mounjaro and Zepbound. We name them only to explain the difference. Compounded tirzepatide is not a generic and is not the same as a brand product. It is not FDA-approved as a finished product, and it is prescription-only. The public Mendoxa offer is the injection. The clinician decides whether it is appropriate and sets the dose.

Compounded vs brand tirzepatide

Brand tirzepatide is FDA-approved. Compounded tirzepatide is not reviewed by the FDA for safety, effectiveness or quality before it reaches you.

Formulation can differ, including the form you take. The clinician should discuss brand alternatives, and if brand access matters to you, say so.

Tirzepatide vs semaglutide

Tirzepatide acts on two receptors and semaglutide on one. In the SURMOUNT-5 trial, adults with obesity and without diabetes lost more weight on brand tirzepatide than on brand semaglutide; the trial tested the brand products, not compounded ones.

Read the full comparison in semaglutide vs tirzepatide.

FDA status and safety warnings

The FDA has issued warnings about compounded GLP-1 products, and describes concerns about compounded versions.

FDA's page on concerns with unapproved GLP-1 drugs used for weight loss, checked on 2026-10-16 (page content current as of 10/01/2026), says compounded drugs are not FDA-approved and that FDA does not review them for safety, effectiveness or quality before they are marketed. It also says compounding may be appropriate only when a patient's medical need cannot be met by an approved drug, or the approved drug is not commercially available. FDA's page may change, so read the current version before you decide. FDA reports adverse events, some needing hospitalization, that may be related to dosing errors with compounded injectable products. Patients sometimes measured and injected the wrong amount, and clinicians sometimes miscalculated doses. FDA also says adverse events from compounded versions are likely underreported. Avoid sellers that describe a product as a lab chemical or "not for human use". Measured doses and clear written instructions matter. Rush Pharmacy, a licensed U.S. compounding pharmacy, prepares Mendoxa prescriptions.

Is compounded tirzepatide still allowed?

FDA's page on compounded GLP-1 drugs names tirzepatide. It says compounded drugs are not FDA approved, and that compounding might be appropriate when a patient's medical need cannot be met by an FDA-approved drug.

The same page says compounding may also apply where the approved drug is not commercially available. It does not address shortage status, so this guide does not either. The page was opened on 2026-10-16 and lists its content as current as of 10/01/2026. Read the current FDA page and ask the prescriber why compounded tirzepatide fits your situation.

Who decides your compounded dose

The prescribing clinician and the pharmacy set a compounded dose and should give you written instructions for it. It is not the brand schedule.

FDA reports adverse events, some requiring hospitalization, that may be related to dosing errors with compounded GLP-1 drugs, from patients measuring and injecting the wrong amount and from clinicians miscalculating doses. FDA advises patients to talk with their health care provider or compounder about how to measure and administer the intended dose. For the brand schedule, read the tirzepatide starting dose guide.

Side effects and who should not take it

Nausea, diarrhea, vomiting, constipation and reduced appetite are the most common side effects, especially as the dose rises.

Serious risks include pancreatitis, gallbladder problems, low blood sugar with some diabetes drugs, and dehydration with kidney problems. Brand tirzepatide carries a boxed warning on thyroid C-cell tumors, so it is not for people with a personal or family history of medullary thyroid cancer or MEN 2. Brand labeling also says tirzepatide can reduce the effect of oral birth control, so patients who use it are advised to switch methods or add a barrier method. Pregnancy is not appropriate. See the tirzepatide prescribing information on DailyMed.

Tirzepatide online: how to check a provider

A legitimate service has a licensed clinician review your history and names the pharmacy that fills it. Mendoxa does both, in 49 states (not California).

The intake asks about your weight history, health conditions and medications. Red flags include no clinician review, no named pharmacy, and lab-chemical products. A prescription is never automatic. LocumTele clinicians review every intake, and Rush Pharmacy fills when a prescription is issued.